« Return to News | Technology Solutions

Schrödinger and ChemAxon extend partnership

Thursday, July 11, 2013 09:30 AM

Schrödinger, a drug discovery solutions company, and ChemAxon, a provider of cheminformatics software platforms and desktop applications for the biotechnology, pharmaceutical and agrochemical industries, have extended their partnership agreement for another five years. ChemAxon will provide the JChem chemistry engine as well as Marvin sketching and rendering functionality to Schrödinger's enterprise informatics platform, Seurat.

A data integration and discovery collaboration platform, Seurat provides decision and project support as well as advanced data exploration, and can consume backend data or replace legacy tools like Accord, ISIS, Isentris or internally-developed customer tools that have reached end of life. Seurat can be installed locally or hosted on either the British Telecom (BT) or Amazon Web Services (AWS) cloud.

"Its long-term nature demonstrates that collaboration between partners with complementary technologies is a sustainable business model in our sector, and can offer a better solution to customers and a more efficient development environment for partners," said Alex Drijver, chief executive officer of ChemAxon.

ChemAxon's JChem chemistry engine, able to be deployed universally and scale to cover big data requirements, is a chemical structure storage and search toolkit. Also included in the provision is the JKlustor functionality for high performance structure library analysis as well as the Marvin editor & viewer which lets users ask chemical questions and see structures as answers.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.